Pharmactive Biotech Products, S.L.U announces its flagship Affron® saffron extract has officially received individual license ...

RANCHO CUCAMONGA - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced Monday it has entered into an exclusive license agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for a ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Your endocrine system regulates many bodily functions, from ...

Ectopic Cushing syndrome (ECS) occurs when a non-pituitary tumour secretes excess adrenocorticotropic hormone, leading to hypercortisolism. ECS is most commonly associated with small cell lung cancer ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in the following two ...

Over the past year, OMass has made meaningful progress across its portfolio, including advancing our lead MC2 antagonist towards the clinic, establishing in vivo efficacy for our first-in-class ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. Company ...

Addison’s disease is treated in dogs by replacing the cortisol and aldosterone hormones they lack. An ACTH stimulation test ...

The standard test for differentiating between pituitary and ectopic adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome is corticotropin-releasing hormone (CRH)-stimulated inferior ...

Nonclassical congenital adrenal hyperplasia (NCAH) can lead to the production of excess male hormones. It is usually a mild condition and often doesn’t need to be treated if there are no symptoms.

Subtle to frank abnormalities in hypothalamic–pituitary axis function are frequently seen in cancer survivors who have received prophylactic or therapeutic cranial irradiation. The growth hormone (GH) ...